Our Mission
Red Leaf Incorporated is a multinational company aimed at the genetic development of the human race and the natural world. Our interests lie in genetic rich species that would prove useful to both our investors and our research. Our reach extends beyond our headquarters in Europe enabling us to sample genetic material far and wide, such as your own. Thus far the company’s greatest achievements have taken place in the most unlikely places, such as our research on Pink Dolphins deep in the Amazon and our study of the Congo Pygmies and their complex breeding habits. It is through these successes, that we hope to undertake the most complex project yet, the Revival of the Tasmanian Tiger.
Opportunities
The opportunities and assets presented in our latest project have massive implications for both our investors and the wider globe. By sourcing the tiger’s genetic material, the company is provided with a key to pandora’s box, unlocking unlimited genetic potential for any investor. Furthermore, a primary DNA strain that has found to be unique to Tasmanian Tigers could also have ramifications on peacekeeping operations as a deterrent to any threat. The neuro depressant can be deployed on mass, only violating a few select codes of the Geneva Conventions. Lastly, customers of a high-profile nature may be eligible to participate in our Reficio programme, poised at creating a new class.
For more information, please visit our investment portfolio:
Bringing Back History
Once the Tiger’s genome has been mapped, possible avenues for the wider public can be made available on a global scale. While opportunities for cloning and distribution have previously been deemed “unprofitable”, contracts with zoos and animal distributors now allow for total monopolisation over an unsaturated market. Additionally, animals would also be made available for customers to add to their private collections or for use as a tool to indulge in other affairs.
The Red Threat
The longer western nations and corporations remain undecisive, the more opportunities communist regimes of the east have to enact their plans and gain an upper hand in any future trade deals. In the last quarter alone, the Chinese Communist Party (CCP) was able to patent and claim 63 strains of DNA from various rare and exotic animals. These patents could potentially lead to the CCP being able to present this new threat as a bargaining chip at any future trade deals, sending ripples across the Global Financial Market. In addition to this, it is likely the CCP would unethically use these biochemical weapons against its own people as a deterrent to uprising or anti party material. Our company, Red Leaf, is morally committed to forging a brighter genetic future for both you and the global community.
Our Staff
Our company takes pride in only staffing “the golden standard” of workers that show devout loyalty and the upmost skill. In doing this, Red Leaf has ensured its continuation of research and service into the foreseeable future, preventing the western world from being “left behind”. Furthermore, the company has been provided the unique unrivalled title of No. 1 in the privatised sector, leading us to exponential growth across the world. Even though we may have thousands in our employ, the company still awards those of great value and working ethic. Red Leaf would not be what it is today without these people.
Visit Heroes of the Company for more information: